Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience

Rowen RJ. Medical Gas Research, 2019.

View the abstract on PubMed

Study type
Review
People studied
No participants of its own (review)
Published
2019, Medical Gas Research
Identifiers
PMID 31898609, DOI 10.4103/2045-9912.273962
Group
Ozone therapy more broadly

What the authors reported

A narrative review arguing ozone therapy could serve as an adjunctive or stand-alone treatment for drug-resistant infections and outbreaks such as Ebola, describing it as having a strong safety record.

What limits this result

A single author's advocacy-oriented narrative review with no systematic search or new controlled data, and no study of ozone against Borrelia or Lyme disease specifically.

Other ozone methods, such as major autohemotherapy, that clinics cite in support of EBO2. A result for one method does not transfer automatically to another. One study rarely settles a medical question; our guides weigh each paper against the rest of the evidence.

How the study was done

Design
Review concentrating on ozone therapy (OT) as a treatment for infection
Setting
Private Medical Practice, Santa Rosa, CA, USA
Read from
Read from the full text of the paper. Read on September 28, 2026.

Sources: Full text on PubMed Central, Abstract on PubMed

Safety as reported

The review cites Jacobs as reporting ozone therapy to be exceptionally safe, with a complication rate of only 0.7 per 100,000 treatments, virtually all due to improper application

Source: Full text on PubMed Central

Funding and conflicts

Conflicts of interest: None

Source: Full text on PubMed Central

Where we cite this study

All studies we track ยท How the studies compare